Bayer's $7.25 Billion U.S. Settlement Over Roundup Sent Back to Missouri Court

By Nina Kienle


Bayer's Monsanto said a U.S. federal judge had sent a $7.25 billion U.S. settlement over its Roundup weedkiller back to the Missouri State Court.

The German pharmaceutical and agricultural conglomerate proposed the settlement in February to resolve claims alleging that Roundup causes cancer, with payments to be made over two decades but front-loaded to this year.

Plaintiffs sought to move the settlement to a federal court in California, but the company said earlier this month that the class settlement case should be remanded to Missouri State Court.

Monsanto said Wednesday that the decision from a federal judge to remand the settlement back to the Missouri State Court brought much-needed clarity to all parties and would allow the class approval process to move forward.

"Monsanto remains confident that the class settlement, which is supported by plaintiffs' counsel representing tens of thousands of potential class members, is fair to all parties and the objections have no merit," the company said.


Write to Nina Kienle at nina.kienle@wsj.com


(END) Dow Jones Newswires

June 17, 2026 11:51 ET (15:51 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.

Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.

Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.

Popular

Sponsor Center